Financials

News Ideas Discussions Technicals Forecast Seasonals Options

SYRE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Spyre Therapeutics, Inc.

Total assets of SYRE for Q1 25 is 569.78 M USD, 6.36% less than the previous Q4 24. And total liabilities decreased by 3.87% in Q1 25 to 87.17 M USD.

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD